{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:27:58Z","timestamp":1793953678054,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique Hopitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.healun.2026.05.028","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:48:12Z","timestamp":1780292892000},"page":"1685-1696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-0480","authenticated-orcid":false,"given":"L\u00e9on","family":"Genecand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ath\u00e9na\u00efs","family":"Boucly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Beurnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-7994","authenticated-orcid":false,"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-7264","authenticated-orcid":false,"given":"Bruno","family":"Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-0996","authenticated-orcid":false,"given":"Christian","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-1951","authenticated-orcid":false,"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Chemla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.05.028_bib2","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.healun.2026.05.028_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01908-2018","article-title":"Clinical trial design and new therapies for pulmonary arterial hypertension","volume":"53","author":"Sitbon","year":"2019","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.healun.2026.05.028_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2026.05.028_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.healun.2026.05.028_bib6","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa2415160","article-title":"Sotatercept in patients with pulmonary arterial hypertension at high risk for death","volume":"392","author":"Humbert","year":"2025","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.healun.2026.05.028_bib7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa2508170","article-title":"Sotatercept for pulmonary arterial hypertension within the first year after diagnosis","volume":"393","author":"McLaughlin","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.healun.2026.05.028_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01107-2023","article-title":"Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial","volume":"62","author":"Souza","year":"2023","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.healun.2026.05.028_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011227","article-title":"SPECTRA Phase 2b Study: impact of sotatercept on exercise tolerance and right ventricular function in pulmonary arterial hypertension","volume":"17","author":"Waxman","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01321-2024","article-title":"Pathophysiology of the right ventricle and its pulmonary vascular interaction","volume":"64","author":"Hemnes","year":"2024","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.healun.2026.05.028_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCRESAHA.118.314438","article-title":"Protective effects of activated myofibroblasts in the pressure-overloaded myocardium are mediated through smad-dependent activation of a matrix-preserving program","volume":"124","author":"Russo","year":"2019","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.healun.2026.05.028_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.201507-1444OC","article-title":"Mechanisms of lipid accumulation in the bone morphogenetic protein receptor type 2 mutant right ventricle","volume":"194","author":"Talati","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.healun.2026.05.028_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurjhf\/hfr140","article-title":"Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension","volume":"13","author":"Wong","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.healun.2026.05.028_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacc.2004.03.060","article-title":"Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry","volume":"44","author":"Fincke","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.healun.2026.05.028_bib16","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.healun.2026.05.028_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00706-2023","article-title":"Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients","volume":"10","author":"Farmakis","year":"2024","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00313-2022","article-title":"Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"8","author":"Farmakis","year":"2022","journal-title":"ERJ Open Res"},{"issue":"9630","key":"10.1016\/j.healun.2026.05.028_bib19","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.healun.2026.05.028_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.healun.2026.05.028_bib21","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.healun.2026.05.028_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.healun.2026.05.028_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"10.1016\/j.healun.2026.05.028_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacc.2021.07.057","article-title":"Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension","volume":"78","author":"Chin","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized trial of macitentan\/tadalafil single-tablet combination therapy for pulmonary arterial hypertension","volume":"83","author":"Grunig","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2026.05.028_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2026.02.5103","article-title":"Sotatercept in pulmonary arterial hypertension: central, hematologic, and peripheral mechanisms of benefit","author":"Reddy","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.healun.2026.05.028_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00246-011-9954-3","article-title":"Pulmonary vascular resistance and viscosity: the forgotten factor","volume":"32","author":"Hoffman","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.healun.2026.05.028_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.healun.2025.10.019","article-title":"Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry","volume":"45","author":"Tello","year":"2026","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.healun.2026.05.028_bib30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1164\/rccm.200910-1643OC","article-title":"Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure","volume":"182","author":"Saouti","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.healun.2026.05.028_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1152\/japplphysiol.00081.2023","article-title":"How to incorporate tricuspid regurgitation in right ventricular-pulmonary arterial coupling","volume":"135","author":"Yoshida","year":"2023","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"10.1016\/j.healun.2026.05.028_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01696-2023","article-title":"Tricuspid regurgitation in pulmonary arterial hypertension: a right ventricular volumetric and functional analysis","volume":"63","author":"Yoshida","year":"2024","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.healun.2026.05.028_bib33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chest.2022.04.011","article-title":"Prognostic value of echocardiographic variables prior to and following initiation of parenteral prostacyclin therapy: an observational study","volume":"162","author":"Shah","year":"2022","journal-title":"Chest"},{"issue":"25_","key":"10.1016\/j.healun.2026.05.028_bib34","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.healun.2026.05.028_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009047","article-title":"Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.healun.2026.05.028_bib36","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.healun.2026.05.028_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.70112","article-title":"The impact of cardiac output methods on the classification of pulmonary hypertension","volume":"15","author":"Genecand","year":"2025","journal-title":"Pulm Circ"},{"issue":"2","key":"10.1016\/j.healun.2026.05.028_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014785","article-title":"Effect of balloon pulmonary angioplasty and riociguat on right ventricular afterload and function in CTEPH: insights from the RACE trial","volume":"18","author":"Gerges","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.healun.2026.05.028_bib39","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.125.076913","article-title":"Acute hemodynamic effects of sotatercept","volume":"152","author":"Kremer","year":"2025","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.healun.2026.05.028_bib40","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.healun.2025.07.032","article-title":"Hemodynamic effects of sotatercept administration in pulmonary hypertension- Insights from remote monitoring","volume":"44","author":"Nagaraj","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.healun.2026.05.028_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"Eur Respir J"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826019364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826019364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:03:58Z","timestamp":1793952238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249826019364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1053249826019364"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.05.028","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}